Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: single arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2006).

Lee TS, Seong SJ, Kim JW, Ryu HS, Song ES, Nam BH.

Jpn J Clin Oncol. 2011 Jun;41(6):817-9. doi: 10.1093/jjco/hyr048. Epub 2011 Apr 7.

PMID:
21478178
2.

Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials.

Abu Hashim H, Ghayaty E, El Rakhawy M.

Am J Obstet Gynecol. 2015 Oct;213(4):469-78. doi: 10.1016/j.ajog.2015.03.037. Epub 2015 Mar 19. Review.

PMID:
25797236
3.

Use of levonorgestrel-releasing intrauterine system in the prevention and treatment of endometrial hyperplasia.

Ewies AA, Alfhaily F.

Obstet Gynecol Surv. 2012 Nov;67(11):726-33. doi: 10.1097/OGX.0b013e318273570b. Review.

PMID:
23151756
4.

The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review.

Buttini MJ, Jordan SJ, Webb PM.

Aust N Z J Obstet Gynaecol. 2009 Jun;49(3):316-22. doi: 10.1111/j.1479-828X.2009.00981.x. Review.

PMID:
19566568
5.

Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis.

Gallos ID, Shehmar M, Thangaratinam S, Papapostolou TK, Coomarasamy A, Gupta JK.

Am J Obstet Gynecol. 2010 Dec;203(6):547.e1-10. doi: 10.1016/j.ajog.2010.07.037. Review.

PMID:
20934679
6.

Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.

Chin J, Konje JC, Hickey M.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007245. doi: 10.1002/14651858.CD007245.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD007245.

PMID:
19821400
7.

Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia.

Luo L, Luo B, Zheng Y, Zhang H, Li J, Sidell N.

Cochrane Database Syst Rev. 2013 Jun 5;(6):CD009458. doi: 10.1002/14651858.CD009458.pub2. Review.

PMID:
23737032
8.

Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.

Dominick S, Hickey M, Chin J, Su HI.

Cochrane Database Syst Rev. 2015 Dec 9;(12):CD007245. doi: 10.1002/14651858.CD007245.pub3. Review.

PMID:
26649916
9.

Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.

Lethaby A, Hussain M, Rishworth JR, Rees MC.

Cochrane Database Syst Rev. 2015 Apr 30;(4):CD002126. doi: 10.1002/14651858.CD002126.pub3. Review.

PMID:
25924648
10.

Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.

Lethaby AE, Cooke I, Rees M.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126. Review. Update in: Cochrane Database Syst Rev. 2015;4:CD002126.

PMID:
16235297
11.

[Current possibilities of examination and preservative treatment in endometrial hyperplasia].

Kołodziejczak M, Knapp P, Kuźmicki M, Knapp P.

Ginekol Pol. 2011 Jul;82(7):514-9. Review. Polish.

PMID:
21913429
12.

Levonorgestrel intrauterine system for endometrial protection.

Sturdee D.

J Br Menopause Soc. 2006 Mar;12 Suppl 1:1-3. Review.

PMID:
16513011
13.

The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review.

Wan YL, Holland C.

Climacteric. 2011 Dec;14(6):622-32. doi: 10.3109/13697137.2011.579650. Epub 2011 Oct 23. Review.

PMID:
22017273
14.

Levonorgestrel-releasing intrauterine system: uses and controversies.

Bahamondes L, Bahamondes MV, Monteiro I.

Expert Rev Med Devices. 2008 Jul;5(4):437-45. doi: 10.1586/17434440.5.4.437. Review.

PMID:
18573044
15.

[Levonorgestrel-releasing intrauterine system Mirena® (Bayer) for the prevention and treatment of endometrial adenocarcinoma and the incidence of other malignancies in women].

Jóźwik M, Jóźwik M, Modzelewska B, Niewińska M, Jóźwik M.

Ginekol Pol. 2015 Apr;86(4):305-10. Review. Polish.

PMID:
26117991
16.
17.

Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system.

Mansour D.

Best Pract Res Clin Obstet Gynaecol. 2007 Dec;21(6):1007-21. Epub 2007 Jun 1. Review.

PMID:
17544330
18.

A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.

Sturridge F, Guillebaud J.

Drug Saf. 1996 Dec;15(6):430-40. Review.

PMID:
8968696
19.
20.

Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: an overview.

Jensen JT.

Obstet Gynecol Surv. 2005 Sep;60(9):604-12. Review.

PMID:
16121115

Supplemental Content

Support Center